CNBC's Jim Cramer analyzed Tuesday's market action and told investors to step back as big winners cool down after huge runs.

Jim Cramer, a stalwart of stock market commentary, recently shifted gears on Bristol-Myers Squibb, pegging his hopes on their ...

The stroke market is experiencing unprecedented growth, fueled by intense corporate investment and disruptive technologies ...

Yale SOM leadership expert Jeffrey Sonnenfeld and co-author Steven Tian argue that Cook’s unmatched track record makes him uniquely positioned to steer the company into its next phase of innovation ...

Merck & Co., Inc. (NYSE:MRK), one of the largest pharmaceutical companies in the world, has lost 15% year-to-date on the ...

Shares of semiconductor company Semtech (NASDAQ:SMTC) jumped 3.2% in the afternoon session after bullish sentiment from Wall Street analysts. The semiconductor company has received a consensus "Buy" ...

AbbVie has updated its 2025 earnings guidance after taking an $823 million acquired in-process R&D (IPR&D) expense in Q2.

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed President Trump’s tariffs and their impact on the ...

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...